These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 9044563)

  • 21. Transdermal delivery system for zidovudine: in vitro, ex vivo and in vivo evaluation.
    Narishetty ST; Panchagnula R
    Biopharm Drug Dispos; 2004 Jan; 25(1):9-20. PubMed ID: 14716748
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination therapy of chloroquine and methimazole in Graves' disease: a pilot randomized controlled trial.
    Soltani A; Moayyeri A; Azizi F
    Biomed Pharmacother; 2007 May; 61(4):241-3. PubMed ID: 17462854
    [No Abstract]   [Full Text] [Related]  

  • 23. Studies on doses of methimazole (MMI) and its administration regimen on broiler metabolism.
    Rosebrough RW; Russell BA; McMurtry JP
    Comp Biochem Physiol A Mol Integr Physiol; 2006 Jan; 143(1):35-41. PubMed ID: 16337159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro and in vivo evaluation of the transdermal iontophoretic delivery of sumatriptan succinate.
    Patel SR; Zhong H; Sharma A; Kalia YN
    Eur J Pharm Biopharm; 2007 May; 66(2):296-301. PubMed ID: 17182233
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transdermal delivery of diclofenac sodium through rat skin from various formulations.
    Sarigüllü Ozgüney I; Yeşim Karasulu H; Kantarci G; Sözer S; Güneri T; Ertan G
    AAPS PharmSciTech; 2006 Oct; 7(4):88. PubMed ID: 17233540
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Severe pancytopenia associated with antithyroid drugs in a patient with Graves' disease and chronic renal failure.
    Macia M; Méndez M; Fernández J; Riverol A; Rios
    Clin Nephrol; 1997 Feb; 47(2):129. PubMed ID: 9049463
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism.
    He CT; Hsieh AT; Pei D; Hung YJ; Wu LY; Yang TC; Lian WC; Huang WS; Kuo SW
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):676-81. PubMed ID: 15163329
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microemulsions as transdermal drug delivery vehicles.
    Kogan A; Garti N
    Adv Colloid Interface Sci; 2006 Nov; 123-126():369-85. PubMed ID: 16843424
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transdermal delivery of phosphorodiamidate Morpholino oligomers across hairless mouse skin.
    Pannier AK; Arora V; Iversen PL; Brand RM
    Int J Pharm; 2004 May; 275(1-2):217-26. PubMed ID: 15081152
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transdermal skin delivery: predictions for humans from in vivo, ex vivo and animal models.
    Godin B; Touitou E
    Adv Drug Deliv Rev; 2007 Sep; 59(11):1152-61. PubMed ID: 17889400
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ex vivo and in vivo evaluation of transdermal formulation of trazodone hydrochloride.
    Das MK; Ghosal SK
    Acta Pol Pharm; 2008; 65(4):481-6. PubMed ID: 19051591
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of an artificial neural network to predict Graves' disease outcome within 2 years of drug withdrawal.
    Orunesu E; Bagnasco M; Salmaso C; Altrinetti V; Bernasconi D; Del Monte P; Pesce G; Marugo M; Mela GS
    Eur J Clin Invest; 2004 Mar; 34(3):210-7. PubMed ID: 15025680
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design, development, physicochemical, in vitro and in vivo evaluation of monolithic matrix type transdermal patches containing nitrendipine.
    Mittal A; Sara US; Ali A; Mohammed A
    Pharm Dev Technol; 2009; 14(4):422-34. PubMed ID: 19630699
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methimazole toxicity in rodents: covalent binding in the olfactory mucosa and detection of glial fibrillary acidic protein in the olfactory bulb.
    Bergman U; Brittebo EB
    Toxicol Appl Pharmacol; 1999 Mar; 155(2):190-200. PubMed ID: 10053173
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Intrahepatic cholestasis in untreated hyperthyroidism].
    Antón Aranda E
    Rev Esp Enferm Dig; 2000 Jan; 92(1):49-50. PubMed ID: 10749600
    [No Abstract]   [Full Text] [Related]  

  • 36. [Preoperative management of patients with thyrotoxicosis].
    Lukomskiĭ GI; Ivanova NA; Kabanova GM
    Khirurgiia (Mosk); 1981 Aug; (8):50-2. PubMed ID: 6170778
    [No Abstract]   [Full Text] [Related]  

  • 37. Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes.
    Dubey V; Mishra D; Dutta T; Nahar M; Saraf DK; Jain NK
    J Control Release; 2007 Nov; 123(2):148-54. PubMed ID: 17884226
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discovery of transdermal penetration enhancers by high-throughput screening.
    Karande P; Jain A; Mitragotri S
    Nat Biotechnol; 2004 Feb; 22(2):192-7. PubMed ID: 14704682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Withdrawal of the parenterally applicable form of thyrostatic drugs in Austria.
    Weissel M
    Thyroid; 2005 Oct; 15(10):1203. PubMed ID: 16279858
    [No Abstract]   [Full Text] [Related]  

  • 40. Withdrawal of the parenterally applicable form of thyrostatic drugs in Austria.
    Weissel M
    Thyroid; 2005 Jul; 15(7):746-7. PubMed ID: 16053395
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.